Sign in

CIK 0000897448

  • Accelerated filer

AMARIN CORP PLCUK

Sign in to watch
Ticker
AMRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+353 16699020
Business address
SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
Former names
AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
  1. 4 Open-market sale Chief Scientific Officer sold 128,257 shares at $4.25 ($545,092)
  2. 4 Shares withheld for taxes President and CEO gave up 15,732 shares (to pay taxes)
  3. 4 Shares withheld for taxes General Counsel gave up 27,885 shares (to pay taxes)
  4. 3/A Insider 3/A
  5. 3 Insider Initial Statement of Ownership
  6. 4/A Insider Changes in Ownership
  7. 4 Open-market buy President and CEO bought 10,000 shares at $3.24 ($32,446)
  8. 4 Open-market sale Chief Scientific Officer sold 63,479 shares at $3.48 ($221,199)
  9. 4 Shares withheld for taxes President and CEO gave up 15,732 shares (to pay taxes)
  10. 4 Shares withheld for taxes General Counsel gave up 27,885 shares (to pay taxes)
  11. 4 Shares withheld for taxes President and CEO gave up 15,732 shares (to pay taxes)
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale General Counsel sold 307,911 shares at an average $4.00 ($1,230,933)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 20 of 31 · 620 filings